Context Evidence suggests that more intensive lowering of low-density lipoprotein cholesterol (LDL-C) than is commonly applied clinically will provide further benefit in stable coronary artery dis.....
相关链接：Treating to New Targets(TNT) Intensive Lipid Lowering with Atorvastatinin Patients with Stable Coronary Disease 阿托伐他汀强化降脂治疗稳定型冠心病 已有文献证实降低低密度脂蛋白.......
Lancet. 2004 Aug; 364(9435):685-696. Colhoun HM， Betteridge DJ， Durrington PN， et al; CARDS investigators. INTERPRETATION: Atorvastatin 10 mg daily is safe and efficacious in reducing the risk of first cardiovascular .....
Lancet. 2004 Aug 21;364(9435):685-96. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled .....
Major outcomes in moderately hypercholesterolemic， hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Hear.....
关注公众号
安卓客户端
